Stay updated on Atacicept in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Atacicept in IgA Nephropathy Clinical Trial page.

Latest updates to the Atacicept in IgA Nephropathy Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov site revision identifier changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check12 days agoChange DetectedThe ClinicalTrials.gov record for the Phase 3 atacicept study in IgA nephropathy is displayed, with its study details, eligibility criteria, treatment arms, outcomes, and related publications.SummaryDifference46%

- Check19 days agoChange DetectedThe site footer revision changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check33 days agoChange DetectedA notice about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check47 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check61 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous content and navigation with an access-restricted message. This reflects an access restriction rather than a substantive change to the study information.SummaryDifference17%

Stay in the know with updates to Atacicept in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atacicept in IgA Nephropathy Clinical Trial page.